Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8807133rdf:typepubmed:Citationlld:pubmed
pubmed-article:8807133lifeskim:mentionsumls-concept:C0038250lld:lifeskim
pubmed-article:8807133lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:8807133lifeskim:mentionsumls-concept:C0009759lld:lifeskim
pubmed-article:8807133lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:8807133lifeskim:mentionsumls-concept:C0856825lld:lifeskim
pubmed-article:8807133lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:8807133lifeskim:mentionsumls-concept:C1515895lld:lifeskim
pubmed-article:8807133pubmed:issue6lld:pubmed
pubmed-article:8807133pubmed:dateCreated1996-11-22lld:pubmed
pubmed-article:8807133pubmed:abstractTextA 37-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia received allogeneic bone marrow transplants after first and second relapses from different HLA-identical brothers. After a third relapse, blood progenitor cells from one of the brothers were infused after six doses of cytarabine 1.5 g/m2 in an attempt to induce a graft-versus-leukemia effect. Seven weeks after the infusion, the patient developed delayed but severe acute graft-versus-host disease (GVHD) including the unusual manifestation of conjunctival involvement.lld:pubmed
pubmed-article:8807133pubmed:languageenglld:pubmed
pubmed-article:8807133pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8807133pubmed:citationSubsetIMlld:pubmed
pubmed-article:8807133pubmed:statusMEDLINElld:pubmed
pubmed-article:8807133pubmed:monthJunlld:pubmed
pubmed-article:8807133pubmed:issn0268-3369lld:pubmed
pubmed-article:8807133pubmed:authorpubmed-author:LazarusH MHMlld:pubmed
pubmed-article:8807133pubmed:authorpubmed-author:SpiroT PTPlld:pubmed
pubmed-article:8807133pubmed:authorpubmed-author:CooperB WBWlld:pubmed
pubmed-article:8807133pubmed:authorpubmed-author:BardensteinDDlld:pubmed
pubmed-article:8807133pubmed:authorpubmed-author:O'DayD GDGlld:pubmed
pubmed-article:8807133pubmed:issnTypePrintlld:pubmed
pubmed-article:8807133pubmed:volume17lld:pubmed
pubmed-article:8807133pubmed:ownerNLMlld:pubmed
pubmed-article:8807133pubmed:authorsCompleteYlld:pubmed
pubmed-article:8807133pubmed:pagination1179-80lld:pubmed
pubmed-article:8807133pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:meshHeadingpubmed-meshheading:8807133-...lld:pubmed
pubmed-article:8807133pubmed:year1996lld:pubmed
pubmed-article:8807133pubmed:articleTitleSevere acute graft-versus-host disease of conjunctivae after allogeneic blood progenitor cell infusion.lld:pubmed
pubmed-article:8807133pubmed:affiliationDepartment of Medicine, Ireland Cancer Center; Cleveland, OH, USA.lld:pubmed
pubmed-article:8807133pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8807133pubmed:publicationTypeCase Reportslld:pubmed